Treatment of opioid use disorder—Prior authorization.

Checkout our iOS App for a better way to browser and research.

A health plan offered to employees, school employees, and their covered dependents under this chapter issued or renewed on or after January 1, 2020, shall provide coverage without prior authorization of at least one federal food and drug administration approved product for the treatment of opioid use disorder in the drug classes opioid agonists, opioid antagonists, and opioid partial agonists.

[ 2019 c 314 § 36.]

NOTES:

Declaration—2019 c 314: See note following RCW 18.22.810.


Download our app to see the most-to-date content.